Verastem Inc (NASDAQ: VSTM) on Friday, plunged -6.35% from the previous trading day, before settling in for the closing price of $7.72. Within the past 52 weeks, VSTM’s price has moved between $4.01 and $11.24.
Annual sales at Healthcare sector company grew by 31.36% over the past five years. The company achieved an average annual earnings per share of 14.37%. With a float of $65.21 million, this company’s outstanding shares have now reached $66.75 million.
Verastem Inc (VSTM) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Verastem Inc is 13.42%, while institutional ownership is 75.63%. The most recent insider transaction that took place on Dec 24 ’25, was worth 629. In this transaction Chief Financial Officer of this company sold 80 shares at a rate of $7.86, taking the stock ownership to the 109,758 shares. Before that another transaction happened on Dec 16 ’25, when Company’s Director sold 592 for $9.14, making the entire transaction worth $5,411. This insider now owns 101,147 shares in total.
Verastem Inc (VSTM) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.6 earnings per share (EPS) for the period topping the consensus outlook (set at -0.74) by 0.14. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.54 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 34.71% during the next five years compared to 31.36% growth over the previous five years of trading.
Verastem Inc (NASDAQ: VSTM) Trading Performance Indicators
Verastem Inc (VSTM) is currently performing well based on its current performance indicators. A quick ratio of 2.55 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 40.70.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.26, a number that is poised to hit -0.54 in the next quarter and is forecasted to reach -1.83 in one year’s time.
Technical Analysis of Verastem Inc (VSTM)
As of the previous 9 days, the stock’s Stochastic %D was 22.80%.
During the past 100 days, Verastem Inc’s (VSTM) raw stochastic average was set at 5.86%, which indicates a significant increase from 1.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.52 in the past 14 days, which was lower than the 0.61 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.89, while its 200-day Moving Average is $7.51. Nevertheless, the first resistance level for the watch stands at $7.60 in the near term. At $7.97, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.17. If the price goes on to break the first support level at $7.02, it is likely to go to the next support level at $6.82. Assuming the price breaks the second support level, the third support level stands at $6.45.
Verastem Inc (NASDAQ: VSTM) Key Stats
Market capitalization of the company is 544.56 million based on 66,776K outstanding shares. Right now, sales total 10,000 K and income totals -130,640 K. The company made 11,240 K in profit during its latest quarter, and -98,520 K in sales during its previous quarter.
